Manufacturing, Fill/Finish

Sep 16, 2015
Preventing contamination requires quality systems to be in place, including routine cleaning, a robust cleaning validation program, and preventive maintenance.
Sep 09, 2015
By BioPharm International Editors
FDA warns that compounded or repackaged drugs stored in certain syringes made by Becton-Dickinson may lose potency because of an interaction with the rubber stopper.
Sep 01, 2015
BioPharm International
Three case studies illustrate some analytical methods important for stability testing.
Aug 07, 2015
By BioPharm International Editors
The new, still unnamed biosciences arm of Emergent BioSolutions will be a separate public company with a focus on novel therapeutics in immuno-oncology.
Aug 01, 2015
BioPharm International
Industry experts discuss challenges, trends, and innovations in fluid handling.
Aug 01, 2015
BioPharm International
Process maps and risk assessments are among the valuable tools operators can apply to reduce the risk of microbial contamination.
Jul 20, 2015
By BioPharm International Editors
Baxter has initiated a voluntary recall of two lots of IV solutions due to the potential presence of particulate matter.
Jul 10, 2015
By BioPharm International Editors
The new project will increase fill/finish manufacturing capacity for select products on FDA’s Drug Shortage Index.
Jul 01, 2015
BioPharm International Multimedia
By BioPharm International Editors
Bill Hartzel, Director Strategic Execution, Advanced Delivery Technologies at Catalent Pharma Solutions, spoke with BioPharm International about blow-fill-seal for aseptic processes.
Jul 01, 2015
BioPharm International
Humans represent the greatest risk for microbial contamination in an aseptic process.
native1_300x100
lorem ipsum